Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
October 16, 2024 08:00 ET
|
Oshi Health
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
US Digestive Health Welcomes Seven New Physicians to Its Practice
October 15, 2024 10:00 ET
|
US Digestive Health
EXTON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the nation’s largest gastroenterology (GI) practices, today announced the addition of seven new physicians to its...
Exciting Advances in Ulcerative Colitis Treatments: Skyrizi Gains Early Momentum Following FDA Approval in June
October 01, 2024 10:51 ET
|
Spherix Global Insights
EXTON, PA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The past twelve months have been transformative for the rapidly evolving ulcerative colitis (UC) market, with a surge in advanced therapies receiving FDA...
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 25 000 €. L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies
September 30, 2024 16:09 ET
|
Biocodex Canada
MONTRÉAL, 30 sept. 2024 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex, une organisation fondée par Biocodex et ayant pour vocation d’inspirer des projets scientifiques explorant le...
Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases
September 30, 2024 16:09 ET
|
Biocodex Canada
Biocodex Microbiota Foundation offers a €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases.
Gastrointestinal Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 386 Deals Signed Since 2016 by the World's Leading Life Science Companies and Universities
September 25, 2024 09:15 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Gastrointestinal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated,...
Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
September 25, 2024 08:16 ET
|
Spherix Global Insights
EXTON, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm, is expanding its specialized offerings to buy-side financial firms...
Compact C-Arm Market to Reach $714.1 Million, Globally, by 2033 at 5.7% CAGR: Allied Market Research
September 23, 2024 10:56 ET
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Compact C-Arm Market by Technology (Fluoroscopy Systems and Flat Detector Systems),...
Despite Projections of a 2024 Adalimumab Biosimilar Boom, Humira Remains Dominant for Now, According to Spherix Global Insights
September 23, 2024 10:18 ET
|
Spherix Global Insights
EXTON, PA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights compiled data from their RealTime Dynamix™ services in Crohn’s Disease, Rheumatoid Arthritis, and Psoriasis, fielded in late...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
September 20, 2024 07:45 ET
|
Regeneron Pharmaceuticals, Inc.
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in...